FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:709 September 3, 1998 Number 10

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Harry Bleiberg, Philippe Rougier, and Hans-Joachim Wilke. 397 pp., illustrated. London, Martin Dunitz, 1998. (Distributed by Mosby, St. Louis.) $125. ISBN 1-85317-377-0.

Colorectal cancer is the fourth most common type of cancer worldwide and accounts for considerable mortality. Refinements in surgical technique and reductions in perioperative mortality have improved outcomes substantially in recent years, and little further progress can be anticipated from traditional surgical therapy. However, adjuvant therapy has now been shown to reduce the recurrence rate and to improve survival. Advances in this form of treatment and enhanced understanding of tumor biology will now lead the way in improving the care of patients with colorectal cancer. The well-written textbook Management of Colorectal Cancer provides readers with a concise overview of the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.